Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1240-1246

  Massey, Karen A ^a   Nicolaou, Anna ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Cyclo oxygenase (COX); Cytochrome P450 (CYP450); Eicosanoid; Lipoxygenase (LOX); Mass spectrometry; Polyunsaturated fatty acid (PUFA)

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; EPOXYICOSATRIENOIC ACID; LINOLEIC ACID; LIPOXYGENASE; POLYUNSATURATED FATTY ACID;

ATHEROSCLEROSIS; CHEMICAL STRUCTURE; ELECTROSPRAY; ENZYME MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; LIPID PEROXIDATION; LIPIDOMICS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VASOCONSTRICTION;

CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS, UNSATURATED; LIPID METABOLISM; LIPOXYGENASE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OXYGEN;

EID: 80053370162     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391240     Document Type: Review

References (50)

1. Kim, W., Khan, N.A., McMurray, D.N., Prior, I.A., Wang, N. and Chapkin, R.S. (2010) Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog. Lipid Res. 49, 250-261
2. Ntambi, J.M. and Bene, H. (2001) Polyunsaturated fatty acid regulation of gene expression. J. Mol. Neurosci. 16, 273-278 (Pubitemid 32664788)
3. Calder, P.C. (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukotrienes Essent. Fatty Acids 75, 197-202
4. Funk, C.D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875
5. Masoodi, M., Mir, A.A., Petasis, N.A., Serhan, C.N. and Nicolaou, A. (2008) Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22, 75-83 (Pubitemid 351156118)
6. Bou Khalil, M., Hou, W., Zhou, H., Elisma, F., Swayne, L.A., Blanchard, A.P., Yao, Z., Bennett, S.A. and Figeys, D. (2010) Lipidomics era: accomplishments and challenges. Mass Spectrom. Rev. 29, 877-929
7. Wenk, M.R. (2010) Lipidomics: new tools and applications. Cell. 143, 888-895
8. Masoodi, M. and Nicolaou, A. (2006) Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20, 3023-3029 (Pubitemid 44569781)
9. Smith, W.L. (2008) Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem. Sci. 33, 27-37
10. Smith, W.L., DeWitt, D.L. and Garavito, R.M. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182
11. Ueno, N., Takegoshi, Y., Kamei, D., Kudo, I. and Murakami, M. (2005) Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 338, 70-76 (Pubitemid 41540538)
12. Buczynski, M.W., Dumlao, D.S. and Dennis, E.A. (2009) Proteomics: an integrated omics analysis of eicosanoid biology. J. Lipid Res. 50, 1015-1038
13. Thuresson, E.D., Lakkides, K.M. and Smith, W.L. (2000) Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J. Biol. Chem. 275, 8501-8507 (Pubitemid 30180197)
14. Kaduce, T.L., Figard, P.H., Leifur, R. and Spector, A.A. (1989) Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J. Biol. Chem. 264, 6823-6830 (Pubitemid 19114791)
15. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G. and Moussignac, R.L. (2002) Resolvins: a family of bioactive products of ω-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037 (Pubitemid 35231761)
16. Woodward, D.F., Carling, R.W., Cornell, C.L., Fliri, H.G., Martos, J.L., Pettit, S.N., Liang, Y. and Wang, J.W. (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol. Ther. 120, 71-80
17. Lecomte, M., Laneuville, O., Ji, C., DeWitt, D.L. and Smith, W.L. (1994) Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269, 13207-13215 (Pubitemid 24206086)
18. Sharma, N.P., Dong, L., Yuan, C., Noon, K.R. and Smith, W.L. (2010) Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. Mol. Pharmacol. 77, 979-986
19. Serhan, C.N., Yacoubian, S. and Yang, R. (2008) Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 3, 279-312 (Pubitemid 351488283)
20. Straus, D.S. and Glass, C.K. (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21, 185-210 (Pubitemid 32303994)
21. Diez-Dacal, B. and Perez-Sala, D. (2010) Anti-inflammatory prostanoids: focus on the interactions between electrophile signaling and resolution of inflammation. TheScientificWorld 10, 655-675
22. Groeger, A.L., Cipollina, C., Cole, M.P., Woodcock, S.R., Bonacci, G., Rudolph, T.K., Rudolph, V., Freeman, B.A. and Schopfer, F.J. (2010) Cyclooxygenase-2 generates anti-inflammatory mediators from ω-3 fatty acids. Nat. Chem. Biol. 6, 433-441
23. Kuhn, H. and O'Donnell, V.B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356 (Pubitemid 43818131)
24. Brash, A.R. (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 23679-23682
25. Murphy, R.C. and Gijon, M.A. (2007) Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379-395 (Pubitemid 47172035)
26. Powell, W.S. and Rokach, J. (2005) Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog. Lipid Res. 44, 154-183 (Pubitemid 40733083)
27. Boeglin, W.E., Kim, R.B. and Brash, A.R. (1998) A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. U.S.A. 95, 6744-6749 (Pubitemid 28278051)
28. Jisaka, M., Kim, R.B., Boeglin, W.E. and Brash, A.R. (2000) Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2. J. Biol. Chem. 275, 1287-1293 (Pubitemid 30051183)
29. Moreno, J.J. (2009) New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem. Pharmacol. 77, 1-10
30. Nigam, S., Zafiriou, M.P., Deva, R., Ciccoli, R. and Roux-Van der Merwe, R. (2007) Structure, biochemistry and biology of hepoxilins: an update. FEBS J. 274, 3503-3512 (Pubitemid 47052415)
31. Serhan, C.N., Yang, R., Martinod, K., Kasuga, K., Pillai, P.S., Porter, T.F., Oh, S.F. and Spite, M. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15-23
32. Oliw, E.H. (1994) Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog. Lipid. Res. 33, 329-354
33. Spector, A.A. (2009) Arachidonic acid cytochrome P450 epoxygenase pathway. J. Lipid Res. 50 (Suppl.), S52-S56
34. Zeldin, D.C. (2001) Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059-36062
35. Konkel, A. and Schunck, W.H. (2011) Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim. Biophys. Acta 1814, 210-222
36. Kroetz, D.L. and Xu, F. (2005) Regulation and inhibition of arachidonic acid ω-hydroxylases and 20-HETE formation. Annu. Rev. Pharmacol. Toxicol. 45, 413-438 (Pubitemid 40261812)
37. Panigrahy, D., Kaipainen, A., Greene, E.R. and Huang, S. (2010) Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev. 29, 723-735
38. Iliff, J.J., Jia, J., Nelson, J., Goyagi, T., Klaus, J. and Alkayed, N.J. (2010) Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat. 91, 68-84
39. Milne, G.L., Yin, H. and Morrow, J.D. (2008) Human biochemistry of the isoprostane pathway. J. Biol. Chem. 283, 15533-15537
40. Song, W.L., Paschos, G., Fries, S., Reilly, M.P., Yu, Y., Rokach, J., Chang, C.T., Patel, P., Lawson, J.A. and Fitzgerald, G.A. (2009) Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J. Biol. Chem. 284, 23636-23643
41. Yin, H., Musiek, E.S., Gao, L., Porter, N.A. and Morrow, J.D. (2005) Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 280, 26600-26611 (Pubitemid 41022258)
42. Musiek, E.S., Breeding, R.S., Milne, G.L., Zanoni, G., Morrow, J.D. and McLaughlin, B. (2006) Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J. Neurochem. 97, 1301-1313 (Pubitemid 43725570)
43. Salomon, R.G. (2005) Levuglandins and isolevuglandins: stealthy toxins of oxidative injury. Antioxid. Redox. Signaling 7, 185-201
44. Catala, A. (2010) A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochem. Biophys. Res. Commun. 399, 318-323
45. Murphy, R.C., Barkley, R.M., Zemski Berry, K., Hankin, J., Harrison, K., Johnson, C., Krank, J., McAnoy, A., Uhlson, C. and Zarini, S. (2005) Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346, 1-42 (Pubitemid 41456623)
46. Rhodes, L.E., Gledhill, K., Masoodi, M., Haylett, A.K., Brownrigg, M., Thody, A.J., Tobin, D.J. and Nicolaou, A. (2009) The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 23, 3947-3956
47. Lundstrom, S.L., Balgoma, D., Wheelock, A.M., Haeggstrom, J.Z., Dahlen, S.E. and Wheelock, C.E. (2011) Lipid mediator profiling in pulmonary disease. Curr. Pharm. Biotechnol. 12, 1026-1052
48. Quehenberger, O., Armando, A.M., Brown, A.H., Milne, S.B., Myers, D.S., Merrill, A.H., Bandyopadhyay, S., Jones, K.N., Kelly, S., Shaner, R.L. et al. (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299-3305
49. Durn, J.H., Marshall, K.M., Farrar, D., O'Donovan, P., Scally, A.J., Woodward, D.F. and Nicolaou, A. (2010) Lipidomic analysis reveals prostanoid profiles in human term pregnant myometrium. Prostaglandins Leukotrienes Essent. Fatty Acids 82, 21-26
50. Gupta, S., Maurya, M.R., Stephens, D.L., Dennis, E.A. and Subramaniam, S. (2009) An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis. Biophys. J. 96, 4542-4551